Articles by Andrew D. Seidman, MD
Panelists discuss data from the ADEPT trial, port considerations, and their hopes for the future of breast cancer therapy.
The panelists discuss clinical trial data and patient preferences surrounding subcutaneous versus IV administration routes.
Panelists discuss how subcutaneous treatments can mitigate time toxicity and improve quality of life.
Panelists discuss how treatment options have changed and if indefinite therapy is still needed for certain patients.
Panelists discuss how to help patients understand the diagnosis and navigate treatment options.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.